A Research Study to See if a Change in Therapy for HIV Infection Can Improve the Immune Response to Treatment

NCT00145795 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Kaletra + Current Dual NRTI Backbone
DRUG: Current Regimen

Sponsor

University of Chicago

Collaborators

[object Object]